Precigen, Inc
company in Blacksburg, United States
PGEN Nasdaq
ISIN US74017N1054 SEC CIK 1356090
Follow Precigen
Weekly email: filings, results
Revenue, last quarter
$74.1M
+2437.6% vs same quarter last year
Net income
$35.8M
+124.4% vs same quarter last year
EPS, diluted
$0.08
+107.5% vs same quarter last year
Operating cash flow
$11.9M
+140.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $9.7M | −$250.6M |
| FY24 | $3.9M | −$126.2M |
| FY23 | $6.2M | −$95.9M |
| FY22 | $26.9M | $28.3M |
| FY21 | $14.3M | −$92.2M |
| FY20 | $32M | −$170.5M |
| FY19 | $90.7M | −$322.3M |
| FY18 | $151.2M | −$509.3M |
| FY17 | $219.5M | −$117M |
| FY16 | $190.9M | −$186.6M |
| FY15 | $173.6M | −$84.5M |
| FY14 | $71.9M | −$81.8M |
| FY13 | $23.8M | −$39M |
| FY12 | $13.8M | −$81.9M |
| FY11 | $8M | −$85.3M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −1141.1% | −2587.8% |
| FY24 | - | −3440.2% | −3215.3% |
| FY23 | - | −1602.5% | −1540.6% |
| FY22 | - | - | 105.2% |
| FY21 | - | - | −646.2% |
| FY20 | - | - | −533% |
| FY19 | - | - | −355.3% |
| FY18 | - | −334.4% | −336.9% |
| FY17 | 84.8% | −62.8% | −53.3% |
| FY16 | 80.2% | −65.6% | −97.7% |
| FY15 | 76.5% | −84.6% | −48.7% |
| FY14 | 84.7% | −97.3% | −113.8% |
| FY13 | 99.9% | −244.2% | −164.1% |
| FY12 | 100% | −545.6% | −594.4% |
| FY11 | - | −1028.7% | −1064.3% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$89.8M |
| FY24 | −$76.8M |
| FY23 | −$68.5M |
| FY22 | −$70M |
| FY21 | −$63M |
| FY20 | −$84.5M |
| FY19 | −$173.8M |
| FY18 | −$165.8M |
| FY17 | −$150.4M |
| FY16 | −$80.6M |
| FY15 | $22.9M |
| FY14 | −$26.2M |
| FY13 | −$55.2M |
| FY12 | −$69M |
| FY11 | −$94.8M |
- Precigen
- Healthcare median
Show the numbers
| Year | Precigen | Healthcare median |
|---|---|---|
| FY25 | −2587.8% | −30.6% |
| FY24 | −3215.3% | −47% |
| FY23 | −1540.6% | −58% |
| FY22 | 105.2% | −80.4% |
| FY21 | −646.2% | −71.8% |
| FY20 | −533% | −62.2% |
| FY19 | −355.3% | −46.2% |
| FY18 | −336.9% | −49.6% |
| FY17 | −53.3% | −45.9% |
| FY16 | −97.7% | −36% |
| FY15 | −48.7% | −37.8% |
| FY14 | −113.8% | −35.5% |
| FY13 | −164.1% | −37.1% |
| FY12 | −594.4% | −29.1% |
| FY11 | −1064.3% | −27.9% |